Adenylate cyclase toxin of Bordetella pertussis: Production, purification, and partial characterization

M. S. Leusch, S. Paulaitis, Richard L Friedman

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Bordetella pertussis produces a number of virulence determinants which contribute to its pathogenicity. One factor, the adenylate cyclase toxin (ACT), has been suggested to directly penetrate human phagocytes and disrupt their normal function by direct production of intracellular cyclic AMP (cAMP). Experiments evaluating the production of cell-associated ACT in liquid cultures of B. pertussis 504 demonstrated that the greatest activity was observed during mid-log-phase growth. Urea extracts of cells harvested during the time of maximal ACT production have been used to purify the toxin with both biological and enzymatic activities. ACT is a protein with an apparent molecular mass of 220 kDa and a isoelectric point of 7.0. The specific activity of purified ACT is 17,000 μmol of cAMP formed per mg per min. The biological specific activity of purified ACT is 6,250 nmol of intracellular cAMP formed per mg per min in 2 x 106 S49 lymphoma cells per ml. Preparations containing 8 μg of ACT completely abrogated the chemiluminescence response of 2 x 106 human neutrophils per ml.

Original languageEnglish (US)
Pages (from-to)3621-3626
Number of pages6
JournalInfection and Immunity
Volume58
Issue number11
StatePublished - 1990

Fingerprint

Adenylate Cyclase Toxin
Cyclic AMP
Bordetella pertussis
Virulence
Isoelectric Point
Phagocytes
Luminescence
Cell Extracts
Urea
Lymphoma
Neutrophils

ASJC Scopus subject areas

  • Immunology

Cite this

Adenylate cyclase toxin of Bordetella pertussis : Production, purification, and partial characterization. / Leusch, M. S.; Paulaitis, S.; Friedman, Richard L.

In: Infection and Immunity, Vol. 58, No. 11, 1990, p. 3621-3626.

Research output: Contribution to journalArticle

@article{7542f5ec7e5a4e61ba7bef5473bd4b1b,
title = "Adenylate cyclase toxin of Bordetella pertussis: Production, purification, and partial characterization",
abstract = "Bordetella pertussis produces a number of virulence determinants which contribute to its pathogenicity. One factor, the adenylate cyclase toxin (ACT), has been suggested to directly penetrate human phagocytes and disrupt their normal function by direct production of intracellular cyclic AMP (cAMP). Experiments evaluating the production of cell-associated ACT in liquid cultures of B. pertussis 504 demonstrated that the greatest activity was observed during mid-log-phase growth. Urea extracts of cells harvested during the time of maximal ACT production have been used to purify the toxin with both biological and enzymatic activities. ACT is a protein with an apparent molecular mass of 220 kDa and a isoelectric point of 7.0. The specific activity of purified ACT is 17,000 μmol of cAMP formed per mg per min. The biological specific activity of purified ACT is 6,250 nmol of intracellular cAMP formed per mg per min in 2 x 106 S49 lymphoma cells per ml. Preparations containing 8 μg of ACT completely abrogated the chemiluminescence response of 2 x 106 human neutrophils per ml.",
author = "Leusch, {M. S.} and S. Paulaitis and Friedman, {Richard L}",
year = "1990",
language = "English (US)",
volume = "58",
pages = "3621--3626",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Adenylate cyclase toxin of Bordetella pertussis

T2 - Production, purification, and partial characterization

AU - Leusch, M. S.

AU - Paulaitis, S.

AU - Friedman, Richard L

PY - 1990

Y1 - 1990

N2 - Bordetella pertussis produces a number of virulence determinants which contribute to its pathogenicity. One factor, the adenylate cyclase toxin (ACT), has been suggested to directly penetrate human phagocytes and disrupt their normal function by direct production of intracellular cyclic AMP (cAMP). Experiments evaluating the production of cell-associated ACT in liquid cultures of B. pertussis 504 demonstrated that the greatest activity was observed during mid-log-phase growth. Urea extracts of cells harvested during the time of maximal ACT production have been used to purify the toxin with both biological and enzymatic activities. ACT is a protein with an apparent molecular mass of 220 kDa and a isoelectric point of 7.0. The specific activity of purified ACT is 17,000 μmol of cAMP formed per mg per min. The biological specific activity of purified ACT is 6,250 nmol of intracellular cAMP formed per mg per min in 2 x 106 S49 lymphoma cells per ml. Preparations containing 8 μg of ACT completely abrogated the chemiluminescence response of 2 x 106 human neutrophils per ml.

AB - Bordetella pertussis produces a number of virulence determinants which contribute to its pathogenicity. One factor, the adenylate cyclase toxin (ACT), has been suggested to directly penetrate human phagocytes and disrupt their normal function by direct production of intracellular cyclic AMP (cAMP). Experiments evaluating the production of cell-associated ACT in liquid cultures of B. pertussis 504 demonstrated that the greatest activity was observed during mid-log-phase growth. Urea extracts of cells harvested during the time of maximal ACT production have been used to purify the toxin with both biological and enzymatic activities. ACT is a protein with an apparent molecular mass of 220 kDa and a isoelectric point of 7.0. The specific activity of purified ACT is 17,000 μmol of cAMP formed per mg per min. The biological specific activity of purified ACT is 6,250 nmol of intracellular cAMP formed per mg per min in 2 x 106 S49 lymphoma cells per ml. Preparations containing 8 μg of ACT completely abrogated the chemiluminescence response of 2 x 106 human neutrophils per ml.

UR - http://www.scopus.com/inward/record.url?scp=0025052628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025052628&partnerID=8YFLogxK

M3 - Article

C2 - 2228232

AN - SCOPUS:0025052628

VL - 58

SP - 3621

EP - 3626

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 11

ER -